Zobrazeno 1 - 10
of 33
pro vyhledávání: '"O. V. Inamova"'
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 1 (2022)
The beginning of the 21st century was marked by a simultaneous changes in view on pathogenesis, diagnostics and treatment of axial spondyloarthritis (axSpA). Anti-TNFα inhibitors were the first biologics prescribed in axSpA. 20 year after the biolog
Externí odkaz:
https://doaj.org/article/e01d53f1480a48da84a49c11b15458e0
Autor:
V. I. Mazurov, A. M. Lila, O. V. Shadrivova, M. S. Tonkoshkur, M. S. Shostak, L. V. Martynova, O. V. Inamova, M. S. Petrova, A. Yu. Fonturenko, E. A. Desyatik, Yu. V. Borzova, Yu. E. Melekhina, I. S. Bogomolova, S. M. Ignatyeva, N. N. Klimko
Publikováno v:
Современная ревматология, Vol 14, Iss 4, Pp 16-22 (2020)
Objective: to study risk factors for invasive aspergillosis (IA), its etiology, clinical manifestations, and treatment efficiency in patients with rheumatic diseases (RD).Patients and methods. The first study of proven and probable IA (EORT/MSGERC, 2
Externí odkaz:
https://doaj.org/article/8947bc4a33c5439588ea624f9c1663dd
Autor:
A. M. Shulman, O. M. Lesnyak, I. Z. Gaidukova, L. P. Surmina, E. N. Ushakova, T. V. Polikarpova, E. V. Vasilyeva, O. V. Inamova
Publikováno v:
Klinicist, Vol 13, Iss 3-4, Pp 59-66 (2020)
Objective. To demonstrate the possibility of having a spondyloarthritic mask of osteomalacia in patients of both sexes.Materials and methods. Two clinical cases of osteomalacia occurring under the mask of spondyloarthritis in patients treated at the
Externí odkaz:
https://doaj.org/article/ea4825be646f484aac4e413b6c49a021
Publikováno v:
Современная ревматология, Vol 13, Iss 4, Pp 18-25 (2019)
The paper presents the data of an original study evaluating the impact of disability associated with a number of rheumatic diseases (RDs) (rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis) on the country's economy, as well as the
Externí odkaz:
https://doaj.org/article/ed510fe4c2894c70a9c9ad64b9874e03
Autor:
V. I. Mazurov, I. B. Belyaeva, E. A. Trofimov, R. R. Samigullina, I. V. Oktyabrskaya, M. S. Petrova, O. V. Inamova, R. A. Bashkinov
Publikováno v:
Современная ревматология, Vol 13, Iss 3, Pp 22-29 (2019)
There are few studies of the efficiency of therapy with disease-modifying antirheumatic drugs (DMARDs) and biological agents (BAs) in patients with early rheumatoid arthritis (eRA) as part of a treat-to-target strategy.Objective: to investigate the e
Externí odkaz:
https://doaj.org/article/c4faf8fb3785402aae8d9e94123194a9
Publikováno v:
Медицинский совет, Vol 0, Iss 17, Pp 114-122 (2017)
Febuxostat, a selective inhibitor of isoforms xantinoxydoreductase, it is an alternative to a limited number of medications to reduce urates levels applied in recent decades. Inhibition of xantinoxydoreductase by febuxostat more is more powder and ef
Externí odkaz:
https://doaj.org/article/20424f6059264643a24086e1ec77595a
Publikováno v:
Медицинский совет, Vol 0, Iss 17, Pp 106-112 (2017)
Gout is a fairly common rheumatic disease, the significance of which becomes an increasingly important interdisciplinary problem. It is known that about 2.5% of men over the age of 30 and women over the age of 50 suffer from gout. By the age of 80 y.
Externí odkaz:
https://doaj.org/article/cb0c3a880f25421d83089179b549f9b0
Autor:
M. Yu. Pervakova, A. L. Chudinov, S. V. Lapin, I. B. Belyaeva, V. I. Mazurov, T. V. Blinova, E. A. Surkova, V. L. Emanuel, O. V. Inamova
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 2, Pp 164-168 (2017)
α1-Antitrypsin (α1-AT) deficiency is a common genetic disorder characterized by low serum α1-AT levels and a clinical manifestation of pulmonary emphysema and liver disease. In addition to its classical manifestations, α1-AT deficiency frequently
Externí odkaz:
https://doaj.org/article/89721449a6d24e1ab71aeb3ed5f352c4
Autor:
O. V. Inamova
Publikováno v:
Научно-практическая ревматология, Vol 41, Iss 4, Pp 33-38 (2003)
Objective. To study vasoregulating function circulating endothelial cells (CEC) number in blood of patients with rheumatoid arthritis (RA) with different activity and clinical features. Material and methods. 102 pts with RA aged 17 to 55 years were e
Externí odkaz:
https://doaj.org/article/15d0b4cf979e47ce8c0e6884038c59c6
Autor:
V. I. Mazurov, I. B. Belyaeva, E. A. Trofimov, I. V. Oktyabrskaya, R. R. Samigullina, А. L. Chudinov, O. V. Inamova
Publikováno v:
Medical alphabet. :28-35
Objective. To study the effect of various basic and genetic engineering biological therapies (infliximab, rituximab, tocilizumab) used as first, second- and third-line drugs in combination with methotrexate on clinical course, quality of life (QOL),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d66d8e9f30b059665284e4732c1d365
https://doi.org/10.33667/2078-5631-2022-29-28-35
https://doi.org/10.33667/2078-5631-2022-29-28-35